Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE1102.0518.45 (+1.7 %)
PREV CLOSE () 1083.60
OPEN PRICE () 1080.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 18437
TODAY'S LOW / HIGH ()1079.75 1106.10
52 WK LOW / HIGH ()581.5 1177
NSE1103.4019.35 (+1.78 %)
PREV CLOSE() 1084.05
OPEN PRICE () 1081.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1103.40 (25)
VOLUME 1642872
TODAY'S LOW / HIGH() 1079.10 1106.95
52 WK LOW / HIGH ()581.25 1177.1
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1986

Management Info :

- Chairman K Nithyananda Reddy - Managing Director

Registered Office :

Address : Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone : 040-23736370 / 23747340

Website : www.aurobindo.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
22Apr Aurobindo Pharma informs about details
Aurobindo Pharma has informed that the Company has received the letters..
08Apr Aurobindo Pharma informs about issuanc
Pursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..
05Apr Aurobindo Pharma informs about disclos
Aurobindo Pharma has confirmed that the Company is not falling under the..
05Apr USFDA concludes inspection at Andhra P
The United States Food and Drug Administration (USFDA) has concluded the..
03Apr Aurobindo Pharma informs about disclos
Aurobindo Pharma has informed that the exchange has received the disclos..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit6237.812304.1
Gross Profit 6872.2 16143.5
Operating Profit 8128.221646.8
Net Sales 26920.3127922.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddy's Lab (BSE)
 6217.15 (4.47%)
M.Cap ( in Cr)
103713.42
Abbott India (BSE)
 25725.00 (1.03%)
M.Cap ( in Cr)
54663.83
Bharat Parenterals (BSE)
 1701.80 (10.00%)
M.Cap ( in Cr)
990.39
Alkem Laboratories (BSE)
 4857.90 (3.10%)
M.Cap ( in Cr)
58083.48
NGL Fine-Chem (BSE)
 2711.85 (3.47%)
M.Cap ( in Cr)
1675.39
Shareholding Pattern
PROMOTERS 51.83%
MUTUAL FUNDS/UTI 17.83%
NON-INSTITUTION 6.87%
FI/BANKS/INSURANCE 5.03%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74339.44486.50 (0.66%)
NIFTY22570.35167.95 (0.75%)
Dow Jones 38460.92-42.77 (-0.11%)
Nasdaq 15712.7516.11 (0.10%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI